Show simple item record
Author | dc.contributor.author | Bejarano, Julian | |
Author | dc.contributor.author | Navarro Márquez, Mario F. | |
Author | dc.contributor.author | Morales Zavala, Francisco | |
Author | dc.contributor.author | Morales, Javier O. | |
Author | dc.contributor.author | García Carvajal, Ivonne | |
Author | dc.contributor.author | Araya Fuentes, Eyleen | |
Author | dc.contributor.author | Flores, Yvo | |
Author | dc.contributor.author | Verdejo, Hugo E. | |
Author | dc.contributor.author | Castro, Pablo F. | |
Author | dc.contributor.author | Lavandero González, Sergio | |
Author | dc.contributor.author | Kogan Bocian, Marcelo | |
Admission date | dc.date.accessioned | 2018-12-20T15:11:45Z | |
Available date | dc.date.available | 2018-12-20T15:11:45Z | |
Publication date | dc.date.issued | 2018 | |
Cita de ítem | dc.identifier.citation | Theranostics, Volumen 8, Issue 17, 2018, Pages 4710-4732 | |
Identifier | dc.identifier.issn | 18387640 | |
Identifier | dc.identifier.other | 10.7150/thno.26284 | |
Identifier | dc.identifier.uri | https://repositorio.uchile.cl/handle/2250/158443 | |
Abstract | dc.description.abstract | © Ivyspring International Publisher. Cardiovascular diseases are the leading cause of death worldwide. Despite preventive efforts, early detection of atherosclerosis, the common pathophysiological mechanism underlying cardiovascular diseases remains elusive, and overt coronary artery disease or myocardial infarction is often the first clinical manifestation. Nanoparticles represent a novel strategy for prevention, diagnosis, and treatment of atherosclerosis, and new multifunctional nanoparticles with combined diagnostic and therapeutic capacities hold the promise for theranostic approaches to this disease. This review focuses on the development of nanosystems for therapy and diagnosis of subclinical atherosclerosis, coronary artery disease, and myocardial infarction and the evolution of nanosystems as theranostic tools. We also discuss the use of nanoparticles in noninvasive imaging, targeted drug delivery, photothermal therapies together with the challenges faced by nanosystems during | |
Lenguage | dc.language.iso | en | |
Publisher | dc.publisher | Ivyspring International Publisher | |
Type of license | dc.rights | Attribution-NonCommercial-NoDerivs 3.0 Chile | |
Link to License | dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/cl/ | |
Source | dc.source | Theranostics | |
Keywords | dc.subject | Atherosclerosis | |
Keywords | dc.subject | Cardiovascular diseases | |
Keywords | dc.subject | Myocardial infarction | |
Keywords | dc.subject | Nanoparticles | |
Keywords | dc.subject | Theranostics | |
Título | dc.title | Nanoparticles for diagnosis and therapy of atherosclerosis and myocardial infarction: Evolution toward prospective theranostic approaches | |
Document type | dc.type | Artículo de revista | |
Cataloguer | uchile.catalogador | SCOPUS | |
Indexation | uchile.index | Artículo de publicación SCOPUS | |
uchile.cosecha | uchile.cosecha | SI | |
Files in this item
- Name:
- item_85053130172.pdf
- Size:
- 2.149Kb
- Format:
- PDF
This item appears in the following Collection(s)
Show simple item record
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile